InvestorsHub Logo
Followers 22
Posts 3706
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Tuesday, 11/03/2020 8:58:58 AM

Tuesday, November 03, 2020 8:58:58 AM

Post# of 8583
Dew & Sir Flo will no longer have to venture to CALI for our in-house FAT & BEAUTIFUL facial treatments. Why, you ask? smile bc RVNC will soon have an outlet in Marlborough, Ma. employing 76.

Marlborough continues to add to reputation as biotech, life sciences hub

Excerpts:
Revance Therapeutics is seeking a tax increment financing deal to open a facility on Campus Drive. Sartorius announced plans last week to expand its North American manufacturing operations with a new facility on Locke Drive in Marlborough.

MARLBOROUGH – The city is continuing to add to its reputation as a hub for life science and biotech companies.

Newark, California-based Revance Therapeutics Inc. – a biotech company – is seeking a tax increment financing deal with the city to open a facility for commercial aseptic fill operations and research and development on Campus Drive.

Marlborough, in recent years, has attracted several life science and biotech companies, bringing hundreds of new jobs to the region.

“Due to its strong and growing commitment to the life sciences industry, Marlborough is rated a Platinum BioReadyTM Community by the Massachusetts Biotechnology Council (MassBio),” Mayor Arthur Vigeant wrote in a letter to the City Council. “This puts the city among the most favorable biotech destinations in the state, just 7% of Massachusetts communities have achieved ‘Platinum status.’ This investment equates to new job opportunities in our community and additional tax revenue ensuring the tax burden does not fall solely on our residents.”

Revance Therapeutics

Revance plans to lease a 79,000 square-foot single-tenant building on Campus Drive and construct parking facilities, the mayor said in his letter.

“Revance Therapeutics will create and maintain 76 permanent, full-time jobs available to qualified residents of Marlborough at the projected area,” Vigeant wrote. “Additionally, improvements to the Project Area are estimated in an initial capital investment of approximately $115 million in combined soft, real property and personal property costs.”

The company – which has about 430 employees – has been in talks with city leaders about opening a facility for the past few months.

Brian Blagg, vice president of engineering, facilities and supply chain, wrote a letter to city officials saying the company’s primary objectives were to find a facility that meets all operational requirements, a location where the company can hire and retain exceptional talent, lower operating costs, operate in a stable and business-friendly environment with an improved tax structure and provide flexibility for future growth.

“Revance Therapeutics is therefore requesting that you accept this letter as the formal letter of intent required under the Economic Development Incentive Program, (EDIP),” Blagg wrote in his letter.

https://marlborough.wickedlocal.com/news/20201102/marlborough-continues-to-add-to-reputation-as-biotech-life-sciences-hub

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News